World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
46345
World Ranking
10673
National Ranking
5488

Overview

Howard I. Hurtig is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on the fields of Medicine and Neuroscience, with significant contributions in Neurology, Physiology, Psychiatry and Mental Health, Cellular and Molecular Neuroscience, and Cognitive Neuroscience.

The scientist's work covers a range of topics, including:

  • Parkinson's Disease Mechanisms and Treatments
  • Alzheimer's disease research and treatments
  • Neurological diseases and metabolism
  • Dementia and Cognitive Impairment Research
  • Amyotrophic Lateral Sclerosis Research
  • Nuclear Receptors and Signaling
  • Autism Spectrum Disorder Research

Some recent publications by Howard I. Hurtig include:

  • Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease, 2020, Neuropathology and Applied Neurobiology
  • Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies, 2024, Acta Neuropathologica
  • ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies, 2020, Acta Neuropathologica
  • Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level, 2024, npj Parkinson s Disease
  • ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's Disease and Dementia with Lewy Bodies, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors collaborating with Hurtig include:

  • Daniel Weintraub
  • Vivianna M. Van Deerlin
  • John Q. Trojanowski
  • John Robinson
  • Edward B. Lee

Howard I. Hurtig's work has been published repeatedly in key venues such as Acta Neuropathologica, Neuropathology and Applied Neurobiology, npj Parkinson s Disease, bioRxiv (Cold Spring Harbor Laboratory), and Movement Disorders.

Best Publications

  • MR Signal Abnormalities at 1.5 T in Alzheimer's Dementia and Normal Aging

    Franz Fazekas;John B. Chawluk;Abass Alavi;Howard I. Hurtig

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions

    Benoit I. Giasson;John E. Duda;Ian V. J. Murray;Qiping Chen

  • Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease

    H.I. Hurtig;J.Q. Trojanowski;J. Galvin;D. Ewbank

  • Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated

    John L Robinson;Edward B Lee;Sharon X Xie;Lior Rennert

  • A controlled trial of rasagiline in early Parkinson disease: The tempo study

    Andrew Siderowf;Matthew Stern;Ira Shoulson;Karl Kieburtz

  • DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

    C. F. Lippa;J. E. Duda;M. Grossman;H. I. Hurtig

  • Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Günter U. Höglinger;Nadine M. Melhem;Dennis W. Dickson;Patrick M A Sleiman

  • Neuropathologic substrates of Parkinson disease dementia.

    David J. Irwin;Matthew T. White;Jon B. Toledo;Sharon X. Xie

  • Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease

    Daniel Weintraub;Staci Hoops;Judy A. Shea;Judy A. Shea;Kelly E. Lyons

  • Neuropathological and Genetic Correlates of Survival and Dementia Onset in Synucleinopathies: A Retrospective Analysis

    David J Irwin;Murray Grossman;Daniel Weintraub;Daniel Weintraub;Howard I Hurtig

  • Frontotemporal dementia: clinicopathological correlations.

    Mark S. Forman;Jennifer Farmer;Julene K. Johnson;Christopher M. Clark

  • Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

    Hanae Nakashima-Yasuda;Kunihiro Uryu;John Robinson;Sharon X. Xie

  • A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

    Michael A. Nalls;Raquel Duran;Grisel Lopez;Marzena Kurzawa-Akanbi

  • Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.

    R L Doty;M B Stern;C Pfeiffer;S M Gollomp

  • Montreal Cognitive Assessment Performance in Patients with Parkinson’s Disease with “Normal” Global Cognition According to Mini-Mental State Examination Score

    Sarra Nazem;Andrew D. Siderowf;John E. Duda;Tom Ten Have

  • Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

    Lorraine V. Kalia;Anthony E. Lang;Lili Naz Hazrati;Shinsuke Fujioka

  • CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.

    A. Siderowf;S.X. Xie;H. Hurtig;D. Weintraub

  • Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.

    John E. Duda;Benoit I. Giasson;Qiping Chen;Tamar L. Gur

  • Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients

    Atsushi Umemura;Jurg L. Jaggi;Howard I. Hurtig;Andrew D. Siderowf

Frequent Co-Authors

John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Andrew Siderowf
Andrew Siderowf University of Pennsylvania
Matthew B. Stern
Matthew B. Stern University of Pennsylvania
Virginia M.-Y. Lee
Virginia M.-Y. Lee University of Pennsylvania
Murray Grossman
Murray Grossman University of Pennsylvania
John E. Duda
John E. Duda University of Pennsylvania
Daniel Weintraub
Daniel Weintraub University of Pennsylvania
Vivianna M. Van Deerlin
Vivianna M. Van Deerlin University of Pennsylvania
Sharon X. Xie
Sharon X. Xie University of Pennsylvania
Steven E. Arnold
Steven E. Arnold Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA can lead to various specialized roles beyond becoming a physician. Many students begin their journey with an online degree in nutrition, opening doors to dietetics, wellness, and research positions. This pathway helps build a foundational knowledge in health sciences and patient care.

For those interested in healthcare management, a cahme accredited online mha is a great choice. This degree prepares graduates for leadership roles in hospitals, clinics, and public health organizations, with flexible coursework ideal for working professionals.

Registered nurses seeking career advancement may consider an online rn to bsn no clinicals program. These provide an efficient pathway to earn a bachelor’s degree, often with no on-site clinical requirements, making it more accessible for those balancing shifts and studies.

Finally, advancing further to nurse leadership or academia is possible by completing the fastest dnp program. These programs allow nurses to achieve the highest clinical degree online in less time, enabling them to meet the growing demands for advanced practice nurses.

Best Scientists Citing Howard I. Hurtig

Trending Scientists